(Q43287021)

English

The role of an alginate suspension on pepsin and bile acids - key aggressors in the gastric refluxate. Does this have implications for the treatment of gastro-oesophageal reflux disease?

scientific article published in August 2009

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

The role of an alginate suspension on pepsin and bile acids - key aggressors in the gastric refluxate. Does this have implications for the treatment of gastro-oesophageal reflux disease? (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

author name string

Vicki Strugala

1

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Jeanine Avis

2

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Ian G Jolliffe

3

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Lesley M Johnstone

4

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Peter W Dettmar

5

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

publication date

1 August 2009

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Journal of Pharmacy and Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

61

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

1021-1028

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

A comparison of the efficacy of the alginate preparation, Gaviscon Advance, with placebo in the treatment of gastro-oesophageal reflux disease

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.08.0005

21 January 2018

Rapid onset of effect of sodium alginate on gastro-oesophageal reflux compared with ranitidine and omeprazole, and relationship between symptoms and reflux episodes

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.08.0005

21 January 2018

Alginate rafts and their characterisation

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.08.0005

21 January 2018

Composition of gastro-oesophageal refluxate

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.08.0005

21 January 2018

Mechanisms underlying duodeno-gastric reflux in man.

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.08.0005

21 January 2018

Effect of high dose omeprazole on gastric pepsin secretion and serum pepsinogen levels in man.

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.08.0005

21 January 2018

Morphological alterations in experimental esophagitis. Light microscopic and scanning and transmission electron microscopic study.

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.08.0005

21 January 2018

The role of pepsin in acid injury to esophageal epithelium

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.08.0005

21 January 2018

Activity/stability of human pepsin: implications for reflux attributed laryngeal disease

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.08.0005

21 January 2018

Toxic bile acids in gastro-oesophageal reflux disease: influence of gastric acidity

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.08.0005

21 January 2018

Bile acids in combination with low pH induce oxidative stress and oxidative DNA damage: relevance to the pathogenesis of Barrett's oesophagus

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.08.0005

21 January 2018

Carcinogenesis in reflux disease--in search for bile-specific effects

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.08.0005

21 January 2018

The bile acid deoxycholic acid has a non-linear dose response for DNA damage and possibly NF-kappaB activation in oesophageal cells, with a mechanism of action involving ROS.

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.08.0005

21 January 2018

Upregulation of the oncogene c-myc in Barrett's adenocarcinoma: induction of c-myc by acidified bile acid in vitro

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.08.0005

21 January 2018

Simultaneous intraesophageal impedance and pH measurement of acid and nonacid gastroesophageal reflux: effect of omeprazole

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.08.0005

21 January 2018

Omeprazole does not reduce gastroesophageal reflux: new insights using multichannel intraluminal impedance technology

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.08.0005

21 January 2018

Inhibition of pepsin activity by alginates in vitro and the effect of epimerization

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.08.0005

21 January 2018

Relevance of volume and proximal extent of reflux in gastro-oesophageal reflux disease

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.08.0005

21 January 2018

Identifiers

10.1211/JPP.61.08.0005

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43287021&oldid=1607411681"